AstraZeneca unit sued over alleged monopoly on blockbuster drug Soliris AstraZeneca's Alexion Pharmaceuticals was sued in Massachusetts federal court on Wednesday in a class action complaint ...

AstraZeneca will share new data across its Vaccines & Immune Therapies portfolio at the 2025 Congress of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID Global 2025) in ...

AstraZeneca’s share price has fallen a long way from its September high, but this may mean an opportunity for me to buy a great stock at a knockdown price. The content of this article is ...

We've identified the following companies as similar to AstraZeneca Pharma India Ltd. because they operate in a related industry or sector. We also considered size, growth, and various financial ...

Mark T. Esser, vice president for vaccines and immune therapies at pharmaceutical giant AstraZeneca, will be the inaugural chief scientific officer and leader of the Paul and Diane Manning Institute ...

FILE – A general view of AstraZeneca offices and the corporate logo in Cambridge, England, Saturday, July 18, 2020. AstraZeneca has recorded a big jump in revenue as it begins to take a profit from ...

IT之家4 月 9 日消息，今日上午，智己创意设计中心执行总监 @IM智己许邓韬 对智己汽车 LOGO 的变化做出了具体的回应，称这次智己汽车的 LOGO 设计焕新，主要从以下三个方面进行了探索：角度，比例，形态。 IT之家附具体回应如下： 随着全新智己 L6 的不断披露 ...

Today's announcement could potentially add to a string of bad tariff news that has cost Roche 10.9%, Lilly 14%, and AstraZeneca stock 14.4% over the past week. Still, it remains to be seen ...

AstraZeneca is a top healthcare company with a robust pipeline of drugs in development. Uber Technologies has been a growth beast in recent years, and robotaxis could open up a huge opportunity ...

Tech giant Apple (AAPL) lost its title as the world's most valuable listed company on Tuesday, after shares in the iPhone maker slid 5% amid volatility around tariffs. The fall in Apple's (AAPL) ...

In the latest market close, Astrazeneca (AZN) reached $64.90, with a -1.35% movement compared to the previous day. The stock's change was more than the S&P 500's daily loss of 1.57%. Elsewhere ...

(IN BRIEF) At ESCMID Global 2025 in Vienna, AstraZeneca will present a comprehensive data package from its Vaccines & Immune Therapies portfolio, featuring 13 abstracts across oral and poster ...